We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Effect of UV-Irradiation on Cutaneous Cicatrices

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00261963
First Posted: December 6, 2005
Last Update Posted: June 5, 2007
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Bispebjerg Hospital
  Purpose
The purpose of this study is to examine the effect of UV-irradiation on human cutaneous cicatrices by clinical examinations and histological, immunohistochemical and biochemical analyses.

Condition Intervention
Skin Cicatrices Device: ultraviolet light

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Single
Primary Purpose: Prevention
Official Title: The Effect of UV-Irradiation on Cutaneous Cicatrices -A Randomised, Controlled Study With Clinical, Skin Reflectance, Histological and Biochemical Evaluations

Resource links provided by NLM:


Further study details as provided by Bispebjerg Hospital:

Estimated Enrollment: 15
Study Start Date: February 2004
Estimated Study Completion Date: August 2006
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 50 Years   (Adult)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Non-smoking volunteers,
  • Skintypes II or III

Exclusion Criteria:

  • Atopic dermatitis,
  • Tendency to produce keloids or hypertrophic scars,
  • Exposure of UV light during the last 3 months,
  • Medical treatment
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00261963


Locations
Denmark
Bispebjerg Hospital
Copenhagen, Copenhagen NV, Denmark, 2400
Sponsors and Collaborators
Bispebjerg Hospital
Investigators
Principal Investigator: Eva Due, MD Bispebjerg Hospital
  More Information

ClinicalTrials.gov Identifier: NCT00261963     History of Changes
Other Study ID Numbers: KF 01-187-03
First Submitted: December 2, 2005
First Posted: December 6, 2005
Last Update Posted: June 5, 2007
Last Verified: June 2007

Additional relevant MeSH terms:
Cicatrix
Fibrosis
Pathologic Processes